IL6 and chronic obstructive pulmonary disease: While sulforaphane (30 mg/d for 4 weeks) reduced exercise-induced IL-6 levels in young healthy men [18], sulforaphane (up to 26.6 mg/d for 4 weeks) did not change inflammatory markers, including IL-6 levels, in patients with chronic obstructive pulmonary disease [41].